Skip to main content

Dr. Quinn is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

See Dr. Quinn's full profile

Already have an account?

  • Office

    170 N Henderson Rd, Suite 310
    King Of Prussia, PA 19406
    Phone+1 215-872-5650

Education & Training

  • Lehigh Valley Health Network
    Lehigh Valley Health NetworkFellowship, Rheumatology, 2019 - 2021
  • Lehigh Valley Health Network
    Lehigh Valley Health NetworkResidency, Internal Medicine, 2017 - 2019
  • Lehigh Valley Health Network
    Lehigh Valley Health NetworkInternship, Internal Medicine, 2016 - 2017
  • Touro College of Osteopathic Medicine
    Touro College of Osteopathic MedicineClass of 2016
  • University of Pennsylvania
    University of PennsylvaniaB.S.E., Bioengineering, 2006 - 2010

Certifications & Licensure

  • PA State Medical License
    PA State License 2016 - 2024
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Rheumatology

Publications & Presentations

PubMed

Journal Articles

  • Medical Ethics during the War on Terror: Detainee Treatment and Experimentation by Health Professionals  
    Quinn TA, Shuster E, Penn Bioethics Journal, 11/1/2011

Books/Book Chapters

Abstracts/Posters

  • Seventh time’s the charm: An elusive case of necrotizing lymphadenitis and refractory hemolytic anemia
    Quinn TA, Dunn PJ, Lehigh Valley Health Network Annual Department of Medicine Research Day, Allentown, PA, 5/13/2020
  • Alemtuzumab Toxicity with Multiple Sclerosis Therapy Mimicking CNS Vasculitis
    Buzard KL, Quinn TA, Ross J, Lehigh Valley Health Network Annual Department of Medicine Research Day, Allentown, PA, 5/13/2020
  • Screening and Treating Hyperlipidemia in Patients on Tofacitinib, Tocilizumab, Sarilumab, and Baracitinib
    Torelli W, Ross J, Quinn TA, Erickson K, Soliman A, Harit A, 2019 ACR/ARP Annual Meeting, 11/10/2019
  • Join now to see all